Mentions
Extended reach
Total likes
Video views
AI synopsis
Discussions reflect a strong interest in the research’s relevance to cancer therapy, with comments like 'targeting DDIT4-AS1 could be a breakthrough,' and mention of the mechanisms involved, such as autophagy suppression. The tone is analytical but optimistic, emphasizing the potential therapeutic benefits and significance of the findings in advancing treatments for TNBC.
Most discussions reinforce the importance of DDIT4-AS1 in TNBC and agree that targeting it could improve chemotherapy outcomes.
Posts demonstrate high interest by highlighting mechanisms like autophagy and the potential for new treatments, with some using technical language.
Various comments delve into molecular details, such as the role of RNA-binding proteins and pathways, showing active engagement with the research.
The emphasis on developing novel therapies and improving patient outcomes suggests a moderate perceived impact.
#TNBC becomes dependent on #autophagy as a source of nutrients during tumor growth. The authors revealed that DDIT4-AS1 is involved in the regulation of autophagy in TNBC, and the knockdown ⬇️ of DDIT4-AS1 suppressed autophagy activity of TNBC cells.
Trending on PubMed: Targeting lncRNA DDIT4-AS1 Sensitizes Triple Negative Breast Cancer to Chemotherapy via Suppressing of Autophagy. https://t.co/Pqx23pwn7F
Targeting lncRNA DDIT4-AS1 Sensitizes Triple Negative Breast Cancer to Chemotherapy via Suppressing of Autophagy https://t.co/WxbWr8kVzM https://t.co/FzJjWPVwYw
Targeting lncRNA DDIT4-AS1 Sensitizes Triple Negative Breast Cancer to Chemotherapy via Suppressing of Autophagy. https://t.co/wzN0LKbB4L
Targeting lncRNA DDIT4-AS1 sensitizes triple-negative breast cancer to chemotherapy by inhibiting autophagy, which promotes tumor survival. Using nanoparticle-delivered siRNA against DDIT4-AS1 improves treatment…
Trending on PubMed: Targeting lncRNA DDIT4-AS1 Sensitizes Triple Negative Breast Cancer to Chemotherapy via Suppressing of Autophagy. https://t.co/Pqx23pwn7F
Targeting lncRNA DDIT4-AS1 Sensitizes Triple Negative Breast Cancer to Chemotherapy via Suppressing of Autophagy. https://t.co/wzN0LKbB4L
#TNBC becomes dependent on #autophagy as a source of nutrients during tumor growth. The authors revealed that DDIT4-AS1 is involved in the regulation of autophagy in TNBC, and the knockdown ⬇️ of DDIT4-AS1 suppressed autophagy activity of TNBC cells.
Targeting lncRNA DDIT4-AS1 Sensitizes Triple Negative Breast Cancer to Chemotherapy via Suppressing of Autophagy https://t.co/WxbWr8kVzM https://t.co/FzJjWPVwYw